Ronald Harold Wilfred Cooper Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ronald Harold Wilfred Cooper.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ronald Harold Wilfred Cooper. Ronald Harold Wilfred Cooper is President and CEO in ALBIREO PHARMA, INC. ($BIOD) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and in Generation Bio Co. ($GBIO).
Latest Insider Trading Transactions of Ronald Harold Wilfred Cooper
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALBO, GBIO, GNCA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | GBIO | Generation Bio Co. | Cooper Ronald Harold Wilfred | Option Exercise | A | 40.20 | 30,000 | 1,206,000 | 30,000 | ||
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 34.88 | 93,000 | 3,243,840 | 93,000 | |
Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Grant | A | 0.00 | 48,700 | 0 | 56,460 | 7.8 K to 56.5 K (+627.58 %) |
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 24.67 | 124,000 | 3,059,080 | 124,000 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 24.04 | 124,000 | 2,980,960 | 124,000 | |
Nov 15 2018 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Buy | P | 25.02 | 1,026 | 25,668 | 7,760 | 6.7 K to 7.8 K (+15.24 %) |
Aug 16 2018 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Buy | P | 32.50 | 200 | 6,500 | 6,734 | 6.5 K to 6.7 K (+3.06 %) |
Aug 16 2018 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Buy | P | 31.63 | 588 | 18,598 | 6,534 | 5.9 K to 6.5 K (+9.89 %) |
Jun 25 2018 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 0.99 | 45,000 | 44,550 | 45,000 | |
Jun 11 2018 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 30.68 | 123,750 | 3,796,650 | 123,750 | |
Aug 23 2017 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 24.48 | 60,000 | 1,468,800 | 60,000 | |
Jun 15 2017 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 5.34 | 15,000 | 80,100 | 15,000 | |
Jan 24 2017 | BIOD | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 19.19 | 55,000 | 1,055,450 | 55,000 | |
Nov 07 2016 | BIOD | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 1.00 | 19,422 | 19,422 | 19,422 | |
Nov 07 2016 | BIOD | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 1.00 | 155,381 | 155,381 | 155,381 | |
Nov 07 2016 | BIOD | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Grant | A | 0.00 | 5,946 | 0 | 5,946 | 0 to 5.9 K |
Jun 10 2016 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 4.64 | 25,000 | 116,000 | 25,000 |
Page: 1